178 related articles for article (PubMed ID: 16372817)
1. [Pharmacogenomics in dermatology].
Harr T; Itin PH
J Dtsch Dermatol Ges; 2005 Mar; 3(3):214-21; quiz 222, 224. PubMed ID: 16372817
[No Abstract] [Full Text] [Related]
2. Pharmacogenomics in dermatology: from susceptibility genes to personalized therapy.
Pincelli C; Pignatti M; Borroni RG
Exp Dermatol; 2009 Apr; 18(4):337-49. PubMed ID: 19348000
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics in dermatology: Taking patient treatment to the next level.
Schweitzer J; Maibach H
J Dermatolog Treat; 2015 Feb; 26(1):94-6. PubMed ID: 24552417
[TBL] [Abstract][Full Text] [Related]
4. [Cytostatic agents in dermatology].
Luger A
Z Hautkr; 1978 Dec; 53(23):857-70. PubMed ID: 726543
[No Abstract] [Full Text] [Related]
5. [Pharmacogenetics].
Hach I; Kirch W
Praxis (Bern 1994); 2008 Oct; 97(21):1127-9. PubMed ID: 18951351
[No Abstract] [Full Text] [Related]
6. [Pharmacogenetics: Important aspects for dermatology].
Merk HF
Hautarzt; 2005 Jan; 56(1):44-7. PubMed ID: 15645192
[TBL] [Abstract][Full Text] [Related]
7. Colchicine in dermatology.
Konda C; Rao AG
Indian J Dermatol Venereol Leprol; 2010; 76(2):201-5. PubMed ID: 20228563
[No Abstract] [Full Text] [Related]
8. Polymorphic cytochrome P450 enzymes and post-marketing drug dosage revisions: clinical relevance to dermatologic therapies.
Saggar S; Maibach HI
Cutan Ocul Toxicol; 2007; 26(3):171-80. PubMed ID: 17687682
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics and migraine: possible implications.
Tfelt-Hansen P; Brøsen K
J Headache Pain; 2008 Feb; 9(1):13-8. PubMed ID: 18217199
[TBL] [Abstract][Full Text] [Related]
10. [Molecular biology and dermatology research].
Orozco Topete R
Rev Invest Clin; 2003; 55(2):168-71. PubMed ID: 12827921
[No Abstract] [Full Text] [Related]
11. Pharmacogenetics in dermatology: a patient-centered update.
Comfere NI; Ikediobi ON; Peters MS; el-Azhary RA; Gibson LE
Int J Dermatol; 2013 Aug; 52(8):1005-12. PubMed ID: 23786543
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics in clinical dermatology.
Ameen M; Smith CH; Barker JN
Br J Dermatol; 2002 Jan; 146(1):2-6. PubMed ID: 11841360
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy in dermatology. Shedding a different light on skin disease.
Lui H; Anderson RR
Arch Dermatol; 1992 Dec; 128(12):1631-6. PubMed ID: 1456759
[No Abstract] [Full Text] [Related]
14. [Autoimmune blistering skin diseases: recent advances].
Joly P
Presse Med; 2010 Oct; 39(10):1040-1. PubMed ID: 20692800
[No Abstract] [Full Text] [Related]
15. Pharmacogenomics and lung transplantation: clinical implications.
Burckart GJ; Hutchinson IV; Zeevi A
Pharmacogenomics J; 2006; 6(5):301-10. PubMed ID: 16520825
[No Abstract] [Full Text] [Related]
16. Personalizing dermatology: the future of genomic expression profiling to individualize dermatologic therapy.
Rizzo AE; Maibach HI
J Dermatolog Treat; 2012 Jun; 23(3):161-7. PubMed ID: 21254882
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenetics/pharmacogenomics in psychiatry].
Ueda M; Ishiguro S; Watanabe T; Saeki Y; Shimoda K
Nihon Rinsho; 2010 Jan; 68(1):155-62. PubMed ID: 20077810
[TBL] [Abstract][Full Text] [Related]
18. How pharmacogenomics of biological response modifiers will influence clinical response and toxicity in dermatology.
Dalle S; Thomas L; Shear NH
Int J Dermatol; 2011 Jan; 50(1):114-8. PubMed ID: 21182511
[TBL] [Abstract][Full Text] [Related]
19. Advances in dermatology in the last 25 years.
Sneddon IB
Br J Clin Pract; 1971 Nov; 25(11):477-84. PubMed ID: 4400691
[No Abstract] [Full Text] [Related]
20. Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.
Tavakolpour S; Darvishi M; Ghasemiadl M
Clin Genet; 2018 Mar; 93(3):481-497. PubMed ID: 29194620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
